Swarajya Logo
  • Morning Brief
  • States
  • Politics
  • Economy
  • Business
  • Culture
  • Infra
  • Defence
  • World
  • Books
  • Ideas
  • Science
  • Technology
  • Heritage
  • Archives
  • News Brief
  • Our Views
  • Magazine
  • Headlines
  • Store

Novavax vaccine

Novavax Vaccine Gets DCGI Approval To Be Authorised To 12 Year Olds And Above In India: Report

Swarajya Staff
3y Health
image

US Biotech Firms Novavax, Inovio Developing Vaccines Against New 'Omicron' COVID Variant

Swarajya Staff
3y Insta
image

Protein Subunit Vaccines Come In From The Cold To Offer India A Ray Of Hope

Y Sasank
3y Business
image

Serum Institute Yet To Receive Raw Material From US To Produce Novavax Covid-19 Vaccine In India: Report

Swarajya Staff
4y Insta
image

Novavax Covid-19 Vaccine Is About 90 Per Cent Effective, Finds Large Study

Bhaswati Guha Majumder
4y News Brief
image

Get Swarajya in your inbox.


About Swarajya

Shaping the modern Indian's worldview, speaking on behalf of those invested in the cultural and economic prosperity of India. Published since 1956.


Swarajya is a publication by Kovai Media Private Limited.

editor@swarajyamag.com

Useful Links

  • About Us
  • Subscriptions Support
  • Editorial Philosophy
  • Press Kit
  • Privacy Policy
  • Terms of Use
  • Code of Conduct
  • Plagiarism Policy
  • Refund & Cancellation Policy

Useful Links

  • About Us
  • Subscriptions Support
  • Editorial Philosophy
  • Press Kit
  • Privacy Policy
  • Terms of Use
  • Code of Conduct
  • Plagiarism Policy
  • Refund & Cancellation Policy

Participate

  • Contact Us
  • Write for us
  • Style Guide
  • Jobs

Stay Connected

  • Artboard 2 Copy 6Created with Sketch.
    Artboard 2 Copy 10Created with Sketch.
    Artboard 2 Copy 7Created with Sketch.
    Artboard 2 Copy 9Created with Sketch.
  • Andriod Logo
  • IOS Logo